FDA — authorised 24 May 1985
- Application: NDA018689
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: RIDAURA
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Ridaura on 24 May 1985
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 24 May 1985.
LEGACY PHARMA holds the US marketing authorisation.